ORAGENICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ORAGENICS, INC. (OGEN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.94 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-02-28.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2014-02-28
- ORAGENICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $1.94M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2012-12-31 | $1.94M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |